These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12489682)

  • 1. Current trends in lead discovery: are we looking for the appropriate properties?
    Oprea TI
    J Comput Aided Mol Des; 2002; 16(5-6):325-34. PubMed ID: 12489682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends in lead discovery: are we looking for the appropriate properties?
    Oprea TI
    Mol Divers; 2002; 5(4):199-208. PubMed ID: 12549672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead-like, drug-like or "Pub-like": how different are they?
    Oprea TI; Allu TK; Fara DC; Rad RF; Ostopovici L; Bologa CG
    J Comput Aided Mol Des; 2007; 21(1-3):113-9. PubMed ID: 17333482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyond.
    Odi R; Bibi D; Wager T; Bialer M
    Epilepsia; 2020 Aug; 61(8):1543-1552. PubMed ID: 32614073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Property distribution of drug-related chemical databases.
    Oprea TI
    J Comput Aided Mol Des; 2000 Mar; 14(3):251-64. PubMed ID: 10756480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a difference between leads and drugs? A historical perspective.
    Oprea TI; Davis AM; Teague SJ; Leeson PD
    J Chem Inf Comput Sci; 2001; 41(5):1308-15. PubMed ID: 11604031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of theoretical methods of calculation of partition coefficients for selected drugs.
    Pyka A; Babuśka M; Zachariasz M
    Acta Pol Pharm; 2006; 63(3):159-67. PubMed ID: 20085219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the molecular properties and metabolism of top prescribed drugs.
    Zhong HA; Mashinson V; Woolman TA; Zha M
    Curr Top Med Chem; 2013; 13(11):1290-307. PubMed ID: 23675936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity.
    Hill AP; Young RJ
    Drug Discov Today; 2010 Aug; 15(15-16):648-55. PubMed ID: 20570751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five.
    Stegemann S; Moreton C; Svanbäck S; Box K; Motte G; Paudel A
    Drug Discov Today; 2023 Feb; 28(2):103344. PubMed ID: 36442594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment-based approach to drug lead discovery: overview and advances in various techniques.
    Fattori D; Squarcia A; Bartoli S
    Drugs R D; 2008; 9(4):217-27. PubMed ID: 18588353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational prediction of octanol-water partition coefficient based on the extended solvent-contact model.
    Kim T; Park H
    J Mol Graph Model; 2015 Jul; 60():108-17. PubMed ID: 26142695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Computerized logP prediction using fragment methods].
    Takácsné NK
    Acta Pharm Hung; 1998 Jan; 68(1):39-48. PubMed ID: 9528148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
    Goldman RC
    Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico prediction of the solubility advantage for amorphous drugs - Are there property-based rules for drug discovery and early pharmaceutical development?
    Kuentz M; Imanidis G
    Eur J Pharm Sci; 2013 Feb; 48(3):554-62. PubMed ID: 23262058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural products as lead structures: chemical transformations to create lead-like libraries.
    Pascolutti M; Quinn RJ
    Drug Discov Today; 2014 Mar; 19(3):215-21. PubMed ID: 24171951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based lead discovery: leads by design.
    Carr RA; Congreve M; Murray CW; Rees DC
    Drug Discov Today; 2005 Jul; 10(14):987-92. PubMed ID: 16023057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.